FDA TENTATIVE APPROVAL

Alembic secures FDA tentative approval for Selexipag Injection

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Uptravi for injection, 1,800 mcg/vial, of Actelion Pharmaceuticals US, Inc. (Actelion).